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Abstract
Background: Type 1 diabetes is an autoimmune disease, while allergic contact dermatitis although immune mediated, is
considered an exposure driven disease that develops due to epicutanous contact with reactive low-molecular chemicals.
The objective of the present study was to experimentally study the effect of contact allergens on the development of
diabetes in NOD mice. As the link between contact allergy and diabetes is yet unexplained we also examined the effect of
provocation with allergens on Natural Killer T (NKT) cells, since involvement of NKT cells could suggest an innate connection
between the two diseases.
Method: NOD mice 4 weeks of age were exposed, on the ears, to two allergens, p-phenylenediamine and 2,4-
dinitrochlorobenzene respectively, to investigate the diabetes development. The mice were followed for a maximum of 32
weeks, and they were either repeatedly exposed to the allergens or only sensitized a week after arrival. The stimulation of
NKT cells by the two allergens were additionally studied in C57BL/6 mice. The mice were sensitized and two weeks later
provocated with the allergens. The mice were subsequently euthanized at different time points after the provocation.
Results: It was found that repeated application of p-phenylenediamine reduced the incidence of diabetes compared to
application with water (47% vs. 93%, P = 0.004). Moreover it was shown that in C57BL/6 mice both allergens resulted in a
slight increment in the quantity of NKT cells in the liver. Application of the allergens at the same time resulted in an
increased number of NKT cells in the draining auricular lymph node, and the increase appeared to be somewhat allergen
specific as the accumulation was stronger for p-phenylenediamine.
Conclusion: The study showed that repeated topical application on the ears with a contact allergen could prevent the
development of diabetes in NOD mice. The contact allergens gave a non-visible, sub-clinical dermatitis on the application
site. The preventive effect on diabetes may be due to stimulation of peripheral NKT cells, as shown for provocation with p-
phenylenediamine in the C57BL/6 mouse. This epicutanous procedure may lead to new strategies in prevention of type 1
diabetes in humans.
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Introduction
Type 1 diabetes is an autoimmune disease in which the b-cells
in the pancreas are destroyed. The incidence of this disease is
increasing [1], and it is therefore of interest to investigate
environmental factors which could modulate the development of
disease. Non-Obese Diabetic (NOD) mice are used to study type 1
diabetes in the animal setting, as female NOD mice spontaneously
develop a disease equivalent to type 1 diabetes. In female NOD
mice, diabetes onset occurs typically from 12 to 14 weeks of age, at
which time a large number of b-cells have been destroyed. From as
early as 3 to 4 weeks of age mononuclear infiltrates can be seen in
the pancreas, and when they reach 25–30 week of age, around
80% of female NOD mice have diabetes [2,3]. Factors that help
promote a type 1 cytokine over a type 2 cytokine response or
disturb this balance, can directly affect diabetes susceptibility in
NOD mice [2].
Type 1 diabetes is considered a Th1 disease and has therefore
been inversely associated with type I allergies. However, since
most b-cells are already destroyed when type 1 diabetes presents,
the Th1 driven pancreatic inflammation diminishes with length of
disease and therefore the inverse association is probably found
only in pre-diabetics and newly diagnosed patients [4]. Asthma,
however, is apparently still inversely associated with type 1
diabetes and autoimmune diseases in general [5,6].
Allergic contact dermatitis is considered a type IV delayed type
hypersensitivity reaction driven by skin exposures to contact
allergens. These are often present in consumer products and
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allergic contact dermatitis can therefore be considered an exposure
driven disease. The allergens are haptens which due to their size
and lipophilic nature can penetrate the skin and interact with
proteins making the hapten-protein molecule immunogenic [7].
The standard method for estimating the relative potency of
contact allergens is the Local Lymph Node Assay (LLNA) [8].
Recent studies using potent contact allergens have shown that
CD8+ T cells are the effector cells of allergic contact dermatitis in
mice, whereas CD4+ T cells behave as down-regulatory cells
[9–12].
We have previously in an epidemiological study shown an
inverse association between type 1 diabetes and allergic contact
dermatitis [13]. On the background of this finding, the idea for the
present study was conceived in which we examine whether
exposure to a contact allergen can prevent the development of
diabetes in NOD mice. The allergens were chosen so that they
were potent as well as representing both an experimental allergen
and a clinical relevant allergen 2,4-dinitrochlorobenzene (DNCB)
and p-phenylenediamine (PPD) respectively.
It has been established that stimulation of Natural Killer T
(NKT) cells can protect NOD mice against diabetes [3,14]. As
contact allergens stimulates NKT cells [15–17], we additionally
explored whether the used allergens actually did influence NKT
cells.
Materials and Methods
The Danish Animal Experimental Council approved the
following experiments.
Local Lymph Node Assay (Prestudy in NOD mice)
The local lymph node assay protocol (LLNA) was performed as
previously described [18]. Briefly 28 NOD/BomTac mice
(Taconic, Ry, Denmark) aged 10 weeks were exposed on both
ears to one of the allergens, either p-phenylenediamine (PPD) or
2,4-dinitrochlorobenzene (DNCB) (Sigma-Aldrich, Brøndby, Den-
mark) or with vehicle. The vehicle was acetone and olive oil 4:1
(AOO). For the PPD groups the concentrations were 1.0, 0.25,
and 0.05% (w/v), and for the DNCB groups the concentrations
were 0.25, 0.05, and 0.01% (w/v). Application was done daily for
three days followed by two days rest. On the sixth day the mice
were injected with tritiated thymidine (TRA310, GE Healthcare,
Brøndby, Denmark), and 5 hours later the mice were euthanized
and the draining auricular lymph node (A-LN) removed. Using
linear regression the concentration needed to induce a stimulation
three times the vehicle stimulation was estimated (EC3).
Diabetes incidence study
To study the incidence rate of diabetes in contact-allergen
exposed mice, we took receipt of 104 female, 3-week-old NOD/
BomTac mice (Taconic, Ry, Denmark). The mice were allocated
to seven groups (Table 1). These groups were further allocated to
exposure with PPD, DNCB, vehicle (AOO) or water (one group).
All groups received 3 topical exposures a week after being
delivered, analogous to the first three days of the LLNA.
Four groups were further exposed repeatedly every two weeks
with a single application until a maximum of 32 weeks of life.
These groups consisted of one group from each of the PPD,
DNCB and AOO exposure groups and the water exposure group
(Table 1).
The first exposure, on the fourth week of life, was epicutaneous
application of 25 mL of a concentration of 0.1%(w/v) of the
allergens (PPD or DNCB) and pure solvent for the other exposure
groups (AOO and water). For the repeated exposures (four groups)
the amount remained at 25 mL, whereas the concentration of
allergen was reduced to 0.01%(w/v). The vehicle (AOO) and
water repeated exposure groups received only AOO or water,
respectively. The dilutions were freshly made immediately before
application.
The experiment ended when the mice were 32-weeks old, at
which time the mice in the repeatedly exposed groups had
received 14 applications of the repeated dose. At 12 weeks of age,
weekly measurements of tail blood glucose commenced. If the
glucose level was equal to or above 14 mmol/L on two
consecutive days, the mice were considered to be diabetic and
were euthanized. At the end of the study the mice still alive in the
PPD repeatedly exposed group were provoked with 25 mL, 0.1%
(w/v) PPD, and euthanized two days later. A histological
examination was made to assess cellular infiltration of the ears
(Fig. 1). All samples were fixed in formalin and stained in
hematoxylin and eosin. The rest of the mice still alive at the end of
the study, were euthanized and their ears were also examined for
cellular infiltration. Additionally we did a cytokine analysis of
blood serum drawn by cardiac puncture at euthanization. The
analysis was done by use of the flow metric Luminex xMAP
technology using beads for the following cytokines TNF-alpha, IL-
1beta, IFN-gamma, IL-4, IL-5, IL-6, IL-10, IL-12 (p40), IL-12
(p70), IL-13, IL-17, MIP-1, TGF-b were from Panomics
(Panomics, Inc., Redwood City, CA, USA). TGF-b was run on
the same plates as the other targets. The staining was done
according to the manufactures guideline.
The cumulative diabetes incidence was evaluated by the
Kaplan-Meier estimation, and the significance was estimated by
the log-rank test. The analysis was done with SPSS version 15.0
(SPSS, Chicago, IL, USA)
NKT cell study
We took receipt of 10-week-old female C57BL/6JBomTac mice
(Taconic, Ry, Denmark). One week after arrival 10 mice were
sensitized with 0.5% (w/v) DNCB in AOO and 10 mice with PPD
0.5% (w/v). Two weeks after sensitization the mice were separated
into ten groups of two mice–accordingly there were five groups
Table 1. Concentrations and groups in the diabetes incidence study.
Exposure
substance PPD PPD DNCB DNCB AOO AOO Water
Groups Induction only Repeated exposure Induction only Repeated exposure ‘‘Induction’’ only
Repeated
exposure
Repeated
exposure
Conc. 4th week 0.1%(w/v) 0.1%(w/v) 0.1%(w/v) 0.1%(w/v) Pure solvent Pure solvent Pure solvent
Conc. Rest of the
weeks
No exposure 0.01%(w/v) No exposure 0.01%(w/v) No exposure Pure solvent Pure solvent
doi:10.1371/journal.pone.0010591.t001
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treated with either allergen. In eight groups the respective allergen
in a concentration of 0.5% (w/v) was re-applied to both ears. At
the following time points after re-application (18, 24, 48, and
72 hours) a group of mice was anaesthetized, fixated and vena
portae was ligated. Vena cava was cut and the mice bled.
Subsequently the liver was perfused with PBS containing heparin
until pale; afterwards the liver was removed along with the
draining auricular lymph node (A-LN). The groups which did not
receive a reapplication, the control groups, were euthanized at
48 hour.
The livers and A-LN’s were strained (70 mm; BD Biosciences,
Brøndby, Denmark), to gain a single cell suspensions, and the liver
lymphocytes were isolated using Lympholyte-M (CEDARLANE
Laboratories, Burlington, Canada). Subsequently the cell suspen-
sions were stained with APC-conjugated CD1d tetramers
(ProImmune, Oxford Science Park, UK) loaded with a-galacto-
sylceramide (Alexis Biochemicals/Axxora, San Diego, USA)
according to the manufacture guidelines. Thereupon the following
cellular receptors were stained; FITC conjugated anti-CD3 (BD
Biosciences, Brøndby, Denmark), PE-Cy5.5 conjugated anti-
TCR-b, PE-Cy7 conjugated anti-NK1.1 (eBioscience, San Diego,
USA) and APC-Cy7 conjugated CD19 (BioLegend, San Diego,
USA). Afterwards the cells were analyzed on a FACSCanto II (BD
Biosciences, Brøndby, Denmark). The CD19 positive cells were
gated out, and TCR-b positive cells were selected. Subsequently
cells in the quadrant containing CD3 positive and CD1d-tetramer-
aGC-positive were designated as CD1d restricted NKT cells. The
number of cells in the A-LN’s in response to the different
exposures can be seen in figure 2. The quantity of NKT cells were
additionally determined as the proportion between NKT cells at
the different time points and the control groups. This was done as
there are very few NKT cells in the A-LN, and there was a small
difference in the number of NKT cells in the control groups (0 h)
(Fig. 2A). Difference between the two exposures was compared
using the Mann-Whitney U test.
Results
By doing a linear regression on the results from the Local
Lymph Node Assay the concentration needed to induce a
stimulation three times the vehicle stimulation was estimated
(EC3). The value were 0.169%(w/v) and 0.037%(w/v) respectively
for PPD and DNCB. These values are close to the EC3 values
previously reported for the CBA mouse [19,20], which is
recommended mouse strain in this protocol. Thus, it is possible
to induce, an easily manageable dermatitis using the two allergens.
On the basis of the estimated EC3 values we decided to use a
concentration of 0.1%(w/v) for sensitization and 0.01%(w/v) for
repeated treatment for both allergens.
The diabetes incidence study revealed that NOD mice
repeatedly exposed to PPD, displayed a cumulative diabetes
incidence of 47%, in contrast to 93% of the water treated group
(P= 0.004). The group repeatedly exposed to DNCB had an
incidence of 92%, and the group which only received the PPD
sensitizing regime 93% (Fig. 3). The three other groups developed
diabetes by a rate similarly with a cumulative incidence from 80–
86% (data not shown).
The cytokine analysis did not reveal any difference between the
exposure groups, and there were no elevated cytokines that could
suggest a systemic response.
Dermatitis was not noticeable by visual inspection, however
sensitization in the group repeatedly exposed to PPD, was
confirmed by a typical lymphocytic infiltration in the ears
following PPD provocation, and a more moderate infiltrate was
also noticeable in the group repeatedly exposed to DNCB (Fig. 1).
The NKT study demonstrated that both allergens influenced
the quantity of NKT cells in an analogous manner in the liver
(data not shown), while PPD appear to influence the amount of
NKT cells more strongly than DNCB in the A-LN’s. A Mann-
Whitney U test was conducted to evaluate the difference between
the A-LN’s. The result of the test on the quantity was significant,
z =22.095, P,0.05, while the result on the number of NKT cells
was insignificant, z =21.567, P.0.05. The quantity of NKT was
calculated by dividing with the number of cells in the control
groups (0 h).
Discussion
Here we describe the intriguing finding that inducing a minor
non-visible dermatitis on a small area, by repeated applications of
PPD, prevents the diabetes development in NOD mice. The
repeated application of allergen gave a sub-clinical dermatitis. This
could not be explained by an abnormal response in NOD mice to
the used allergens, as the NOD mice reacted similar to the
standard mouse strain used for LLNA. Moreover we found that
both allergens modulated the number of NKT cells in the liver,
which is in accordance with previous published data [16].
Figure 1. Mononuclear infiltrations in the ears after exposure to contact allergen. The figure shows hematoxylin and eosin stained ears
from a mouse in the group of mice repeatedly exposed to PPD and provoked with a higher dose at the end of the study (A), and from a mouse from
the group repeatedly exposed to DNCB (B). The H&E stained DNCB ear is representative of the repeatedly exposed mice. The H&E stained PPD ear
shows an increase in infiltration which rules out that they were tolerized to the allergen and the reduced incidence could be due to bystander
suppression.
doi:10.1371/journal.pone.0010591.g001
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It is indicated that repeated application of a contact allergen can
give a Th2 cytokine milieu [21], which may be a mechanism for
the protective effect of repeated application of PPD. The lack of
effect of DNCB is not clear, though it may be related to the
absence of a peripheral NKT cell response compared to that of
PPD. The discrepancy in the allergens ability in hindering diabetes
Figure 2. Topical exposure stimulates NKT cells in A-LN’s. The figures show the number of NKT cells in the A-LN. The A-LN cells were gated to
exclude nonviable cells and sample data were collected on 300,000 cells. It can be seen that both allergens stimulates NKT cells in the A-LN though
PPD appear to be a stronger or longer stimulator. The increase in cells are followed by a steep drop that may be due to down regulation of the T cell
receptor which have been reported previously [35]. Panel A and B shows different experiments. A Mann-Whitney U test was conducted on the
experiment in panel A while panel B is included to show other experiments. The Mann-Whitney U tests performed on the experiment in panel A was
performed on both the quantity of NKT in relation to the control groups (0 h) and on the number of NKT cells. For the quantity of NKT cells the Mann-
Whitney U test was significant (z =22.095, P,0.05) while the result for the number of NKT cells was insignificant (z =21.567, P.0.05).
doi:10.1371/journal.pone.0010591.g002
Figure 3. Repeated application of PPD inhibits the development of diabetes in NOD mice. The figure shows a Kaplan-Meier curve of the
diabetes incidence for four groups of mice. DNCB-rep, PPD-rep and Water, refers to the groups of mice that were repeatedly exposed to DNCB, PPD
or water every other week. PPD-induc refers to the group of mice that was only exposed to PPD in the fourth week of life. The NOD mice exposed to
PPD repeatedly, displayed a cumulative diabetes incidence of 47%, in contrast to 93% of the water treated group (P = 0.004). The log-rank test for all
the shown curves gives a significance of P = 0.008.
doi:10.1371/journal.pone.0010591.g003
Hapten Prevents Diabetes
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may be due to difference in potency as there is a factor four
differences between their potency, however there were no
difference in ear infiltration. Furthermore a cytokine analysis of
cardiac blood drawn at euthanization did not show any differences
between the exposure groups, and could therefore not reveal the
presences of a systemic inflammation. As the mice are sensitized at
a very young age, it could be that the more potent allergen
(DNCB) has somewhat tolerized the mice, and that the allergic
response therefore is not strong enough to inhibit the diabetes
progression. However the ear infiltration in the groups were
comparable, which do not support this hypothesis, and high doses
of contact allergens applied epicutanously have not previously
been reported to tolerize mice. This could be due to the so-called
danger signal, the irritant effect of contact allergens [22] which can
causes toxic effects if the amount used is to large. High-dose
tolerance have therefore be achieved though intravenous injection
of contact allergens [23,24]. Alternatively the PPD groups could
have been subjected to low zone tolerance [25], however the PPD
group that was treated repeatedly was provocated at the end of the
incidence study and the histology of these mice ears showed that
the mice were sensitized (Fig 1A). The lack of effect of DNCB hints
to other experiments with lower doses of DNCB. PPD could
however also be a special contact allergen, as it can induce
immediate hypersensitivity [26,27], and there might additionally
be a differences in the duration of time at which the allergens are
bound in the skin. PPD has been shown to have a long persistency
in the skin [28]. Moreover there could be a difference in the time
span of the cytokine response, as it has previously been shown in
THP-1 cells that the release of IL-8 decreases much faster in cells
treated with DNCB compared to treatment with PPD [29].
The peripheral stimulation of NKT cells by contact allergens is
in agreement with a recent human study [17]. The mechanism for
the protective effect of allergic contact dermatitis on diabetes is
unknown, but activation of NKT cells could be an explanation,
since up-regulation of NKT cells have been shown to protect
NOD mice against diabetes [3,14], and PPD gave a more
pronounced NKT cell response in the A-LN (Fig. 2). The
difference between PPD and DNCB in the peripheral activation of
NKT cells might then explain the selective protective effect of
PPD. For the study on NKT cells we wished to study the effect on
mature 14-weeks-old mice. Therefore the C57BL/6 mouse was
chosen instead of the NOD mice, as this would have required
insulin treatment which potentially could influence the results.
NOD mice were furthermore not chosen to study NKT cells, as
NOD mice have systemic deficiency of NKT cells [30], and
additional are the number of NKT cells in periphery somewhat
reduced [31], hindering efficient evaluation of the effect of contact
allergens on NKT cells.
This study investigates the inhibitory effect of contact allergens
on diabetes development. The repeated epicutanous application of
the contact allergens gave a local harmless subclinical dermatitis.
The application involved only the outside of the ears, which is in
contrast to the systemic and immunological unspecific treatments
with anti-CD3 [32] and complete Freund’s adjuvant [33] or the
systemic treatment with BCG vaccination [34].
In conclusion, we show that controlled repeated epicutanous
exposures to a contact allergen prevent development of diabetes in
the NOD mouse. The mechanism may be a skewing of the
immune system towards Th2 cells which has been described in
studies where the allergen has been reapplied several times and
peripheral up-regulation of NKT cells may additionally play a role
in the preventive effect. This observation may lead to a new
understanding of the integrated immune function and might lead
to a new strategy for prevention of type 1 diabetes.
Acknowledgments
We are grateful for the fruitful discussion with Thomas Osterbye (Bartholin
Institute, Copenhagen).
Author Contributions
Conceived and designed the experiments: KE KB TM JDJ. Performed the
experiments: KE AKH. Analyzed the data: KE. Contributed reagents/
materials/analysis tools: KE. Wrote the paper: KE KB AKH TM JDJ.
References
1. EURODIAB ACE Study Group (2000) Variation and trends in incidence of
childhood diabetes in Europe. EURODIAB ACE Study Group. Lancet 355:
873–876.
2. Anderson MS, Bluestone JA (2005) The NOD mouse: a model of immune
dysregulation. Annu Rev Immunol 23: 447–485.
3. Cardell SL (2006) The natural killer T lymphocyte: a player in the complex
regulation of autoimmune diabetes in non-obese diabetic mice. Clin Exp
Immunol 143: 194–202.
4. Olesen AB, Juul S, Birkebaek N, Thestrup-Pedersen K (2001) Association
between atopic dermatitis and insulin-dependent diabetes mellitus: a case-
control study. Lancet 357: 1749–1752.
5. Cardwell CR, Shields MD, Carson DJ, Patterson CC (2003) A meta-analysis of
the association between childhood type 1 diabetes and atopic disease. Diabetes
Care 26: 2568–2574.
6. Tirosh A, Mandel D, Mimouni FB, Zimlichman E, Shochat T, et al. (2006)
Autoimmune diseases in asthma. Ann Intern Med 144: 877–883.
7. Cavani A, De PO, Girolomoni G (2007) New aspects of the molecular basis of
contact allergy. Curr Opin Allergy Clin Immunol 7: 404–408.
8. Basketter DA (2008) Skin sensitization: strategies for the assessment and
management of risk. Br J Dermatol 159: 267–273.
9. Xu H, DiIulio NA, Fairchild RL (1996) T cell populations primed by hapten
sensitization in contact sensitivity are distinguished by polarized patterns of
cytokine production: interferon gamma-producing (Tc1) effector CD8+ T cells
and interleukin (Il) 4/Il-10-producing (Th2) negative regulatory CD4+ T cells.
J Exp Med 183: 1001–1012.
10. Kehren J, Desvignes C, Krasteva M, Ducluzeau MT, Assossou O, et al. (1999)
Cytotoxicity is mandatory for CD8(+) T cell-mediated contact hypersensitivity.
J Exp Med 189: 779–786.
11. Saint-Mezard P, Berard F, Dubois B, Kaiserlian D, Nicolas JF (2004) The role of
CD4+ and CD8+ T cells in contact hypersensitivity and allergic contact
dermatitis. Eur J Dermatol 14: 131–138.
12. Vocanson M, Hennino A, Cluzel-Tailhardat M, Saint-Mezard P, Benetiere J,
et al. (2006) CD8+ T cells are effector cells of contact dermatitis to common skin
allergens in mice. J Invest Dermatol 126: 815–820.
13. Engkilde K, Menne´ T, Johansen JD (2006) Inverse relationship between allergic
contact dermatitis and type 1 diabetes mellitus: a retrospective clinic-based
study. Diabetologia 49: 644–647.
14. Poulton LD, Baxter AG (2001) Clinical application of NKT cell assays to the
prediction of type 1 diabetes. Diabetes Metab Res Rev 17: 429–435.
15. Nieuwenhuis EE, Gillessen S, Scheper RJ, Exley MA, Taniguchi M, et al. (2005)
CD1d and CD1d-restricted iNKT-cells play a pivotal role in contact
hypersensitivity. Exp Dermatol 14: 250–258.
16. Campos RA, Szczepanik M, Lisbonne M, Itakura A, Leite-De-Moraes M, et al.
(2006) Invariant NKT Cells Rapidly Activated via Immunization with Diverse
Contact Antigens Collaborate In Vitro with B-1 Cells to Initiate Contact
Sensitivity. J Immunol 177: 3686–3694.
17. Gober MD, Fishelevich R, Zhao Y, Unutmaz D, Gaspari AA (2008) Human
natural killer T cells infiltrate into the skin at elicitation sites of allergic contact
dermatitis. J Invest Dermatol 128: 1460–1469.
18. Dean JH, Twerdok LE, Tice RR, Sailstad DM, Hattan DG, et al. (2001)
ICCVAM evaluation of the murine local lymph node assay. Conclusions and
recommendations of an independent scientific peer review panel. Regul Toxicol
Pharmacol 34: 258–273.
19. Warbrick EV, Dearman RJ, Lea LJ, Basketter DA, Kimber I (1999) Local lymph
node assay responses to paraphenylenediamine: intra- and inter-laboratory
evaluations. J Appl Toxicol 19: 255–260.
20. Basketter DA, Gerberick F, Kimber I (2007) The local lymph node assay and the
assessment of relative potency: status of validation. Contact Dermatitis 57:
70–75.
21. Harada D, Takada C, Tsukumo Y, Takaba K, Manabe H (2005) Analyses of a
mouse model of the dermatitis caused by 2,4,6-trinitro-1-chlorobenzene
(TNCB)-repeated application. J Dermatol Sci 37: 159–167.
Hapten Prevents Diabetes
PLoS ONE | www.plosone.org 5 May 2010 | Volume 5 | Issue 5 | e10591
22. Martin SF, Jakob T (2008) From innate to adaptive immune responses in contact
hypersensitivity. Current Opinion in Allergy and Clinical Immunology 8:
289–293.
23. Nakano Y, Nakano K (1981) Induction of Contact Sensitivity and Antigenic-
Competition by the Intravenous Administration of Contact Sensitizers.
Immunology 42: 111–118.
24. Furue M, Tamaki K (1985) Induction and Suppression of Contact Sensitivity to
Fluorescein Isothiocyanate (Fitc). Journal of Investigative Dermatology 85:
139–142.
25. Seidel-Guyenot W, Perschon S, Dechant N, Alt R, Knop J, et al. (2006) Low
zone tolerance induced by systemic application of allergens inhibits T(C)1-
mediated skin inflammation. Journal of Allergy and Clinical Immunology 117:
1170–1177.
26. Bonefeld CM, Larsen JM, Dabelsteen S, Geisler C, White IR, et al. (2009)
Consumer available permanent hair dye products cause major allergic immune
activation in an animal model. Br J Dermatol.
27. Edwards EK, Edwards EK (1984) Contact Urticaria and Allergic Contact-
Dermatitis Caused by Paraphenylenediamine. Cutis 34: 87–88.
28. White JM, Basketter DA, Pease CK, Sanders DA, McFadden JP (2007)
Intermittent exposure to low-concentration paraphenylenediamine can be
equivalent to single, higher-dose exposure. Contact Dermatitis 56: 262–265.
29. Mitjans M, Marinovich M, Lucchi L, Galli CL, Corsini E (2007) Role of p38
MAPK in chemical allergen-induced selective production of IL-8 in naive THP-
1 cells. Toxicology Letters 172: S86–S87.
30. Gombert JM, Herbelin A, Tancrede-Bohin E, Dy M, Carnaud C, et al. (1996)
Early quantitative and functional deficiency of NK1+-like thymocytes in the
NOD mouse. Eur J Immunol 26: 2989–2998.
31. Wu L, Van Kaer L (2007) Role of NKT cells in the digestive system. II. NKT
cells and diabetes. Am J Physiol Gastrointest Liver Physiol 293: G919–G922.
32. Kaufman A, Herold KC (2009) Anti-CD3 mAbs for treatment of type 1
diabetes. Diabetes Metab Res Rev.
33. Sadelain MW, Qin HY, Lauzon J, Singh B (1990) Prevention of type I diabetes
in NOD mice by adjuvant immunotherapy. Diabetes 39: 583–589.
34. Gazda LS, Baxter AG, Lafferty KJ (1996) Regulation of autoimmune diabetes:
characteristics of non-islet-antigen specific therapies. Immunol Cell Biol 74:
401–407.
35. Crowe NY, Uldrich AP, Kyparissoudis K, Hammond KJL, Hayakawa Y, et al.
(2003) Glycolipid antigen drives rapid expansion and sustained cytokine
production by NK T cells. Journal of Immunology 171: 4020–4027.
Hapten Prevents Diabetes
PLoS ONE | www.plosone.org 6 May 2010 | Volume 5 | Issue 5 | e10591
